MEDICINAL AGENT REDUCING CHOLESTEROL CONTENT IN BLOOD SERUM, OR MEDICINAL AGENT FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS Russian patent published in 2008 - IPC A61K45/06 A61K31/397 A61P3/06 A61P9/10 

Abstract RU 2328307 C2

FIELD: medicine; pharmacology.

SUBSTANCE: invention concerns medicinal agent reducing cholesterol content in blood serum or medicinal agent for prevention and treatment of atherosclerosis consisting of combined compound of general formula 1 and inhibitors of cholesterol biosynthesis, medicinal set including this agent, and method of cholesterol reduction in blood serum or prevention and treatment of atherosclerosis.

EFFECT: effective cholesterol reduction in blood serum or prevention and effective treatment of atherosclerosis.

13 cl, 14 tbl, 2 ex

Similar patents RU2328307C2

Title Year Author Number
MEDICINAL COMBINATION COMPRISING (E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULFONYL)AMINO]PYRIMIDINE-5-YL]-(3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIC ACID AND INHIBITOR, INDUCTOR OR SUBSTRATE FOR P-450 3A4 ISOZYME 2000
  • Raza Ali
  • Pirs Dzhon Stjuart
  • Khatchinson Khauard Dzherard
  • Shnek Dennis
  • Baba Takakhiko
  • Touti Akira
  • Jamaguti Jositaka
RU2233162C2
MEDICAL DRUGS FOR TREATMENT OF REPEATED HYPERTENSION WITH HYPERURICEMIA AND/OR HYPERCHOLESTEREMIA 2004
  • Tomijama Akira
  • Tomijama Khirosi
  • Mijamoto Khidetosi
  • Khajasi Keiitiro
  • Motizuki Seiitiro
RU2344820C2
SUGAR RESIDUE-SUBSTITUTED 2-AZETHIDINONES USEFUL FOR USING AS HYPOCHOLESTEROLEMIC PREPARATIONS 2001
  • Gosal Anima
  • Zbajda Shmuel
  • Chaudkhuri Svaran K.
  • Jannuchi Robert M.
  • Feng Venking
  • Olton Kevin B.
  • Patrik Dzhejms E.
  • Dehjvis Kharri R.
RU2297422C2
ANTIHYPERLIPIDEMIC AGENT (VARIANTS) 2002
  • Trifonova O.Ju.
  • Khazanov V.A.
RU2228746C1
APPLICATION FOR TREATING AND PREVENTING ATHEROSCLEROSIS OF PROTEIN-PEPTIDE COMPLEX (HEREINAFTER PPC) OBTAINED FROM EMBRYONIC NERVE TISSUE OR OF QUICK FROZEN EMBRYO BRAIN OF FARM HOOFED ANIMALS AFFECTING CHECK TRANSPORT CHOLESTEROL FROM VASCULAR WALL AND PROFILE OF ACTIVATION OF MONOCYTES IN PATIENTS WITH MANIFESTED ATHEROSCLEROSIS OF GREAT VESSELS OR WITH PREDISPOSITION TO CARDIOVASCULAR DISEASES AND METHOD FOR PREVENTING AND TREATING PATIENTS WITH ARTERIAL ATHEROSCLEROSIS AND DISEASES CAUSED BY ATHEROSCLEROSIS OF MAJOR AND PERIPHERAL VASCULAR CEREBRAL, HEART, AORTA AND LOWER EXTREMITIES (TWO VERSIONS) 2014
  • Nazarenko Anna Borisovna
RU2586286C2
ORTHO-SUBSTITUTED BENZOYLGUANIDINES AND MEDICINAL AGENT BASED ON THEREOF 1997
  • Vajkhert Andreas
  • Brendel' Joakhim
  • Kleemann Khajnts-Verner
  • Lang Khans Jokhen
  • Shvark Jan-Robert
  • Al'Bus Udo
  • Shol'Ts Vol'Fgang
RU2214397C2
APPLICATION OF SUBSTITUTED CYANOPYROLIDINES AND COMBINED PREPARATIONS CONTAINING THEM FOR TREATMENT OF LIPIDEMIA AND ASSOCIATED DISEASES 2003
  • Kholms Dejvid Grenvill
  • Kh'Juz Tomas Ehduard
RU2362555C2
AGENT FOR TREATING DIABETES, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DISEASES 2011
  • Balazovskij Mark Borisovich
  • Antonov Viktor Georgievich
  • Ignatenko Oleg Aleksandrovich
RU2482868C1
HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENT 2007
  • Okunevich Irina Viktorovna
  • Khnychenko Ljudmila Konstantinovna
  • Sapronov Nikolaj Sergeevich
RU2372923C2
AGENT FOR BLOOD CHOLESTEROL CONTENT DECREASE, PHARMACEUTICAL COMPOSITION 1993
  • Lehrri Dzhon Blehk
  • Khenri Ulman Brajant
  • Dzhordzh Dzhozef Kullinan
  • Rajmond Frehnsis Kauffman
RU2123335C1

RU 2 328 307 C2

Authors

Tomijama Khirosi

Jokota Masajuki

Kosakai Kazukhiro

Dates

2008-07-10Published

2004-06-15Filed